三种血清生物标志物对斯里兰卡蝰蛇咬伤后全身中毒早期检测的价值
该研究纳入2020年7月至2021年6月阿努拉德普勒教学医院收治的237例确诊蛇咬伤患者,入院时检测sPLA2活性、sNGAL浓度和sClu浓度等。全身中毒定义为存在蛇毒诱导消耗性凝血病、神经毒性、急性肾损伤或非特异性临床效应。入院sPLA2活性对所有蛇咬伤全身中毒的AUC-ROC为0.72(95%CI 0.66-0.79),在圆斑蝰咬伤中AUC-ROC为0.90(95%CI 0.76-1.00),而sNGAL和sClu预测价值差。sPLA2活性>23.5 nmol/min/mL预测全身中毒的敏感性41%(95%CI 34%-49%)、特异性97%(95%CI 91%-99.5%);在圆斑蝰咬伤中>46 nmol/min/mL的敏感性67%(95%CI 55%-77%)、特异性100%(95%CI 51%-100%)。
要点
- 在全部蛇咬伤中,入院sPLA2活性预测全身中毒的AUC-ROC为0.72(95%CI 0.66-0.79),为三种标志物中最佳。
- 在圆斑蝰咬伤中,sPLA2活性预测全身中毒的AUC-ROC达0.90(95%CI 0.76-1.00),且在咬伤后2小时内就诊者中预测更佳。
- sPLA2活性>23.5 nmol/min/mL预测全部蛇咬伤全身中毒的敏感性41%(95%CI 34%-49%)、特异性97%(95%CI 91%-99.5%)。
- 圆斑蝰咬伤中,sPLA2活性>46 nmol/min/mL预测全身中毒的敏感性67%(95%CI 55%-77%)、特异性100%(95%CI 51%-100%)。
- sNGAL和sClu浓度在圆斑蝰、 hump-nosed viper及无毒蛇咬伤三组间无差异,对全身中毒预测价值差。
适用人群与场景
- 2020年7月至2021年6月斯里兰卡阿努拉德普勒教学医院收治的所有确诊蛇咬伤患者,共237例(圆斑蝰72例、hump-nosed viper 80例、无毒蛇31例、未识别蛇咬伤54例),中位年龄42岁(IQR 29-53岁),男性173例(73%)。
- 纳入标准:确诊蛇咬伤且入院时留有足够抗蛇毒血清前血清样本。
诊断标准与关键阈值
- 全身中毒定义:存在蛇毒诱导消耗性凝血病、神经毒性、急性肾损伤或非特异性临床效应。
- sPLA2活性>23.5 nmol/min/mL预测全部蛇咬伤全身中毒的敏感性41%(95%CI 34%-49%)、特异性97%(95%CI 91%-99.5%)。
- sPLA2活性>46 nmol/min/mL预测圆斑蝰咬伤全身中毒的敏感性67%(95%CI 55%-77%)、特异性100%(95%CI 51%-100%)。
研究设计与关键结果
- 研究类型:诊断准确性研究;纳入237例确诊蛇咬伤患者,全身中毒发生于圆斑蝰咬伤68例(94%)、hump-nosed viper咬伤48例(60%)、未识别蛇咬伤45例(83%)。
- sPLA2活性中位数:圆斑蝰中毒72 nmol/mL/min(IQR 30-164),hump-nosed viper中毒12 nmol/mL/min(IQR 9-16),无毒蛇咬伤11 nmol/mL/min(IQR 9-14);sNGAL和sClu浓度三组间无差异。
- 全身中毒患者sPLA2活性中位数16 nmol/min/mL(IQR 11-59),无全身中毒患者11 nmol/min/mL(IQR 9-14),中位数差5 nmol/min/mL(95%CI 4-12)。
- 入院sPLA2活性预测全部蛇咬伤全身中毒的AUC-ROC 0.72(95%CI 0.66-0.79),sNGAL和sClu预测价值差;圆斑蝰咬伤中AUC-ROC 0.90(95%CI 0.76-1.00),咬伤后2小时内就诊者中预测更佳。
证据类型、等级与局限
- 证据类型:诊断准确性研究(单中心,斯里兰卡阿努拉德普勒教学医院,2020年7月至2021年6月)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为sPLA2活性是蛇咬伤后全身中毒的早期预测指标,尤其在圆斑蝰咬伤和早期就诊者中。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: Early detection of systemic envenoming is critical for early antivenom therapy to minimize morbidity and mortality from snakebite. We assessed the diagnostic utility of 3 serum biomarkers in the early detection of systemic envenoming in viper bites in rural Sri Lanka.
METHODS: All confirmed snakebite patients admitted to Teaching Hospital Anuradhapura from July 2020 to June 2021 were included. On admission, blood was collected for venom concentrations, prothrombin time/international normalized ratio, fibrinogen concentration, serum creatinine concentration, and 3 serum biomarkers, namely secretory phospholipase A2 (sPLA2) activity, neutrophil gelatinase-associated lipocalin (sNGAL) concentration, and clusterin (sClu) concentration. Systemic envenoming was defined by the presence of venom-induced consumption coagulopathy, neurotoxicity, acute kidney injury, or the presence of nonspecific clinical effects.
RESULTS: A total of 237 confirmed snakebite patients (Russell's viper, 72; hump-nosed viper, 80; nonvenomous snakes, 31; and unidentified bites, 54) with sufficient preantivenom serum samples were recruited [median age: 42 years (interquartile range [IQR] 29 to 53 years); 173 men (73%)]. Systemic envenoming occurred in 68 (94%) Russell's viper bites, 48 (60%) hump-nosed viper bites, and 45 (83%) unidentified bites. The median sPLA2 activity was 72 nmol/mL/min (IQR 30 to 164) for Russell's viper envenoming, 12 nmol/mL/min (IQR 9 to 16) for hump-nosed viper envenoming, and 11 nmol/mL/min (IQR 9 to 14) for nonvenomous bites. There was no difference in sNGAL and sCLu concentrations among the 3 groups. The median sPLA2 activity of patients with systemic envenoming was 16 nmol/min/mL (IQR 11 to 59) compared to 11 nmol/min/mL (IQR 9 to 14) in patients without systemic envenoming; the difference between medians was 5 nmol/min/mL (95% confidence interval [CI] 4 to 12). The area under the receiver operator characteristic curve (AUC-ROC) of admission sPLA2 activity was the best predictor of systemic envenoming in all snakebites (AUC-ROC 0.72, 95% CI 0.66 to 0.79), whereas sNGAL and sClu concentrations were poor predictors. sPLA2 activity was a better predictor of systemic envenoming in Russell's viper bites (AUC-ROC 0.90, 95% CI 0.76 to 1.00) and in those presenting within 2 hours of a bite. A sPLA2 activity more than 23.5 nmol/min/mL had a sensitivity of 41% (95% CI 34% to 49%), and a specificity of 97% (95% CI 91% to 99.5%) in predicting systemic envenoming. A sPLA2 activity of more than 46 nmol/min/mL on admission had a sensitivity of 67% (95% CI 55% to 77%) and a specificity of 100% (95% CI 51% to 100%) in predicting systemic envenoming in Russell's viper bites.
CONCLUSIONS: sPLA2 activity is an early predictor of systemic envenoming following snakebite, particularly in Russell's viper bites and in those who present early.
参考来源
- Wedasingha S, Silva A, Fakes K, et al. Utility of Three Serum Biomarkers for Early Detection of Systemic Envenoming Following Viper Bites in Sri Lanka. Ann Emerg Med. 2024. PMID: 39127955. doi:10.1016/j.annemergmed.2024.06.023
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。